Company: INTS
Filing Date: 2025-06-13
Form Type: 8-K
Source: 0001628280-25-031311
Chunk: 4

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-06-13
Form: 8-K
Item: Item 9.01
Chunk 4
---
Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are being filed herewith:

  Exhibit No.      Document                                                                                      
          1.1      Underwriting Agreement, dated June 11, 2025, by and between the Company and ThinkEquity LLC.  
          4.1      F orm of Representative ’ s Warrant (included in Exhibit 1.1)                                 
          5.1      Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P. C.                               
         99.1      Press Release dated June 11, 2025.                                                            
         99.2      Press Release dated June 11, 2025.                                                            
         23.1      Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P. C. (included in Exhibit 5.1).    
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document).                  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                           Intensity Therapeutics, Inc.                               
  Date: June 13, 2025      By:                               /s/ Lewis H. Bender      
                                                             Lewis H. Bender          
                                                             Chief Executive Officer